Dupilumab Improves Symptoms of Anxiety and Depression in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Three Phase 3 Trials (LIBERTY AD SOLO 1 and 2 and ADOL)

Main Article Content

Jonathan I Silverberg
Weily Soong
Benjamin Lockshin
Abhijit Gadkari
Zhen Chen
Ashish Bansal


Atopic Dermatitis, Biologics, Dupilimab, Mental Health, Anxiety, Depression


Abstract not available.


1. Weidinger S, Novak N. Lancet. 2016;387:1109-22.

2. Yu SH, Silverberg JI. J Invest Dermatol. 2015;135:3183-6.

3. Eckert L, et al. J Am Acad Dermatol. 2017;77:274-9.

4. Silverberg JI, et al. J Invest Dermatol. 2019;139:1388-91.

5. Macdonald LE, et al. Proc Natl Acad Sci U S A. 2014;111:5147-52.

6. Murphy AJ, et al. Proc Natl Acad Sci U S A. 2014;111:5153-8.

7. Gandhi NA, et al. Nat Rev Drug Discov. 2016;15:35-50.

8. Gandhi NA, et al. Expert Rev Clin Immunol. 2017;13:425-37.

9. Simpson EL, et al. N Engl J Med. 2016;375:2335-48.

10. Simpson EL, et al. JAMA Derm. 2019; Nov 6 [Epub ahead of print]. doi: https://doi.org/10.1001/jamadermatol.2019.3336.

Most read articles by the same author(s)

1 2 > >>